![Wolfgang Barth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Wolfgang Barth is currently working as a Development Director at AC Immune SA since 2013.
Previously, he held positions as a Director-Project Management at Bayer Corp., a Principal at Bayer AG, and a Member-Supervisory Board at Hypothekenbank Frankfurt AG.
From 2004 to 2008, he served as a Vice President-Development at Avontec GmbH.
He also worked as the Head-Development at TRIN Pharma GmbH.
Dr. Barth holds a doctorate degree from Philipps University of Marburg.
Anciens postes connus de Wolfgang Barth
| Sociétés | Poste | Fin |
|---|---|---|
Avontec GmbH
 Avontec GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic treatments for inflammatory disease | Corporate Officer/Principal | 18/06/2008 |
Hypothekenbank Frankfurt AG
 Hypothekenbank Frankfurt AG Financial ConglomeratesFinance Mortgage Bank | Directeur/Membre du Conseil | 13/07/2006 |
TRIN Pharma GmbH
 TRIN Pharma GmbH Medical/Nursing ServicesHealth Services Develops small molecule drugs for an effective tumor treatment | Corporate Officer/Principal | - |
| AC IMMUNE SA | Corporate Officer/Principal | - |
| BAYER AG | Corporate Officer/Principal | - |
Formation de Wolfgang Barth
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
AC Immune SA
 AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
Hypothekenbank Frankfurt AG
Hypothekenbank Frankfurt AG Financial ConglomeratesFinance Mortgage Bank | Finance |
Avontec GmbH
Avontec GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic treatments for inflammatory disease | Health Technology |
Philipps University of Marburg
 Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TRIN Pharma GmbH
TRIN Pharma GmbH Medical/Nursing ServicesHealth Services Develops small molecule drugs for an effective tumor treatment | Health Services |
